share_log

信達生物:董事會召開日期

INNOVENT BIO: DATE OF BOARD MEETING

香港交易所 ·  Feb 29 05:09
Summary by Moomoo AI
信達生物製藥有限公司宣布將於2024年3月20日(星期三)召開董事會會議。會議的主要目的是考慮及批准公司及其附屬公司截至2023年12月31日止年度的全年業績報告及其發佈。此外,董事會還將在會議中考慮建議派發末期股息。這項宣布由公司主席兼執行董事俞德超博士於2024年2月29日發出。
信達生物製藥有限公司宣布將於2024年3月20日(星期三)召開董事會會議。會議的主要目的是考慮及批准公司及其附屬公司截至2023年12月31日止年度的全年業績報告及其發佈。此外,董事會還將在會議中考慮建議派發末期股息。這項宣布由公司主席兼執行董事俞德超博士於2024年2月29日發出。
SINDA BIOPHARMACEUTICAL CO., LTD. ANNOUNCES THAT IT WILL HOLD A BOARD MEETING ON WEDNESDAY, MARCH 20, 2024. THE MAIN PURPOSE OF THE MEETING IS TO CONSIDER AND APPROVE THE ANNUAL RESULTS REPORT AND ITS PUBLICATION FOR THE YEAR ENDED 31 DECEMBER 2023 OF THE COMPANY AND ITS SUBSIDIARIES. In addition, the Board will consider the proposed distribution of a final dividend at the meeting. The announcement was made by the Chairman and Executive Director of the Company, Dr. Yu Te-chao, on 29 February 2024.
SINDA BIOPHARMACEUTICAL CO., LTD. ANNOUNCES THAT IT WILL HOLD A BOARD MEETING ON WEDNESDAY, MARCH 20, 2024. THE MAIN PURPOSE OF THE MEETING IS TO CONSIDER AND APPROVE THE ANNUAL RESULTS REPORT AND ITS PUBLICATION FOR THE YEAR ENDED 31 DECEMBER 2023 OF THE COMPANY AND ITS SUBSIDIARIES. In addition, the Board will consider the proposed distribution of a final dividend at the meeting. The announcement was made by the Chairman and Executive Director of the Company, Dr. Yu Te-chao, on 29 February 2024.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more